SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-23-274103
Filing Date
2023-11-09
Accepted
2023-11-09 08:49:25
Documents
11
Effectiveness Date
2023-11-09

Document Format Files

Seq Description Document Type Size
1 S-3ASR d580991ds3asr.htm S-3ASR 418654
2 EX-1.2 d580991dex12.htm EX-1.2 217638
3 EX-4.3 d580991dex43.htm EX-4.3 295280
4 EX-4.5 d580991dex45.htm EX-4.5 98046
5 EX-4.6 d580991dex46.htm EX-4.6 96992
6 EX-4.7 d580991dex47.htm EX-4.7 83929
7 EX-5.1 d580991dex51.htm EX-5.1 27415
8 EX-23.1 d580991dex231.htm EX-23.1 1669
9 EX-FILING FEES d580991dexfilingfees.htm EX-FILING FEES 65219
10 GRAPHIC g580991dsp108.jpg GRAPHIC 3879
11 GRAPHIC g580991g76y26.jpg GRAPHIC 34846
  Complete submission text file 0001193125-23-274103.txt   1359582
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: S-3ASR | Act: 33 | File No.: 333-275419 | Film No.: 231390253
SIC: 2836 Biological Products, (No Diagnostic Substances)